# Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

> **NCT00600769** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at Tyler** · enrollment: 210 (actual)

## Conditions studied

- Nontuberculous Mycobacteria
- Mycobacterium Avium Complex

## Interventions

- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT00600769
- **Lead sponsor:** The University of Texas Health Science Center at Tyler
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-01
- **Primary completion:** 2006-11
- **Final completion:** 2017-05-18
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600769, "Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00600769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*